Back
Corporate News
Windlas Biotech to review quarterly results at board meeting on August 10, 2026
04-Aug-2026, 06:15
Windlas Biotech Limited will hold a board meeting on August 10, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2026, according to a regulatory filing. The company’s trading window has been closed since July 1, 2026, and will reopen 48 hours after the financial results are declared.
Windlas Biotech Limited will hold a board meeting on August 10, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2026, according to a regulatory filing. The company’s trading window has been closed since July 1, 2026, and will reopen 48 hours after the financial results are declared.